Semaglutide (brand name Wegovy) is a medication that mirrors a natural hormone called glucagon-like peptide-1 (GLP-1), which is responsible for regulating your appetite
Food and Drug Administration (FDA) database from 2004 to 2009 reported increased risks of pancreatic and thyroid cancer associated with the GLP-1 receptor agonist (GLP-1RA) exenatide compared to other therapies [8]
And studies have found that many people who take them for diabetes or weight loss experience surprising side effects
The mechanism of action involves binding to GLP-1 receptors found throughout the body, particularly in the pancreas, brain, and gastrointestinal tract
Medical Expertise at Pure Harmony At Pure Harmony Med Spa, we don't guess we assess
Standard dose escalation The typical semaglutide dose escalation schedule follows this pattern: Weeks 1-4: 0.25mg once weekly Weeks 5-8: 0.5mg once weekly Weeks 9-12: 1.0mg once weekly Weeks 13-16: 1.7mg once weekly Week 17 onward: 2.4mg once weekly (maintenance dose for weight management) This escalation exists for a reason